Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial.

ABSTRACT:

SUBMITTER: Kalil AC 

PROVIDER: S-EPMC8523116 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature